Lung Cancer Treatments

L'incisione è lunga 6- 7 cm , parte dal punto di mezzo della clavicola e si prolunga in basso ed all'esterno lungo il solco deltoideo pettorale. Kimmel Comprehensive Cancer Center at Johns Hopkins has been dedicated to better understanding human cancers and finding more effective treatments. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. NCI-EORTC-AACR symposium on new drugs in cancer therapy.

A retrospective study of the natural history of patients with liver metastases from colorectal cancer.

Pharmacokinetic considerations on resistance to anticancer drugs.

Anderson Cancer Center experience and prognostic factors.

The biochemical mechanism of selective heat sensitivity of cancer cells.

Isolated hypoxic perfusion with mitomycin C in patients with advanced pancreatic cancer.

International Conference on New Anticancer Agents.

Can the Spitzer Quality of Life Index help to reduce prognostic uncertainty in terminal care? Prognostic value of quality of life scores in terminal cancer patients. Hyperthermic perfusion with chemotherapy for cancer of the extremities. Sloan-Kettering Cancer Center, composed of Memorial Hospital for Cancer and Allied Diseases and Sloan-Kettering Institute, is dedicated to excellence in the prevention, treatment, and cure of cancer through patient care, research, and education. A systematic overview of chemotherapy effects in colorectal cancer. The use of intravascular balloon catheters for isolation of the pelvic vascular bed during pump-oxigenator perfusion of cancer chemotherapeutic agents. Isolated liver perfusion in advanced metastases of colorectal cancers. Pelvic stopflow infusion (PSI) and hypoxic pelvic perfusion (HPP) with mitomycin and melphalan for recurrent rectal cancer. CIIP è di 32-33 ° C; a ciò concorre il solo fatto di mantenere l'addome aperto per un lungo periodo di tempo senza essere riscaldato (fase di citoriduzione). Della quarta generazione liposomiale fa parte la doxorubicina liposomiale pegilata, definita stealth in quanto capace di evadere il sistema immune, caratterizzata da lunga emivita, farmacocinetica favorevole ed accumulo specifico nei tessuti tumorali.

Clinical symptoms and length of survival in patients with terminal cancer.

Negli ultimi anni sono state invece poste le basi per una “terapia genica” mirata su caratteristiche specifiche della cellula cancerosa, mediante gli oligonucleotidi antisenso (OAS). The relative accuracy of the clinical estimation of the duration of life for patients with end of life cancer. TNFα, prolungando in questo modo la risposta clinica. Current treatment for liver metastases from colorectal cancer. Hutchinson Center, interdisciplinary team of world-renowned scientists and humanitarians work together to prevent, diagnose and treat cancer. Continuous hyperthermic peritoneal perfusion for peritoneal dissemination of gastric cancer. Management of peritoneal surface component of ovarian cancer.

Hyperthermic pelvic isolation-perfusion in the treatment of refractory pelvic cancer.

Leucocyte-lymphocyte ratio as prognostic indicator of survival in cachectic cancer patients.

Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer.

Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy.

Ciò perché, per lungo tempo la CP è stata considerata una patologia non suscettibile di un trattamento curativo ed in particolare di un intervento chirurgico. Un recente studio randomizzato ha messo a confronto dacarbazina con o senza antisenso bcl-2 nel trattamento di 771 pazienti con melanoma avanzato; l'antisenso è stato somministrato per via endovenosa continua prolungata per ovviare alla scarsa emivita plasmatica. Metabolic aspects of the role of hyperthermia in mammalian cell inactivation and their possible relevance to cancer treatment.

XV Congress of the Italian Cancer Society.

Unendurable symptoms as prognostic indicators of impending death in terminal cancer patients.

European Organization for Research and Treatment of Cancer Malignant Melanoma Cooperative Group Protocol 18832, tha World Health Organization Melanoma Program Trial 15, and the North American Perfusion Group Southwest Oncology Group-8593.

The natural history of hepatic metastases from colorectal cancer. Randomized Trial of Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Versus Systemic Chemotherapy and Palliative Surgery in Patients With Peritoneal Carcinomatosis of Colorectal Cancer. Morbidity and mortality analysis of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the coliseum technique. Quality of life of cancer patients at different stages in the disease trajectory.

Managing the peritoneal surface component of gastrointestinal cancer.

Isolated hepatic perfusion with tumor necrosis factor and melphalan for unresectable cancers confined to the liver.

Isolated liver perfusion with mitomycin-C in the treatment of colorectal cancer metastases confined to the liver.

Hypoxic pelvic perfusion with mitomycin C using a simplified balloon-occlusion technique in the treatment of patients with unresectable locally recurrent rectal cancer. Surgical treatment and other regional treatments for colorectal cancer liver metastases. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. Clinical prediction of survival is more accurate than the Karnofsky performance status in estimating life span of terminally ill cancer patients.

Amplatz Super Stiff (lunghezza 180 cm) nel catetere diagnostico.

Current status of isolated hepatic perfusion with or without tumor necrosis factor for the treatment of unresectable cancers confined to liver.

Leave a Reply